Verna Welch, PhD, MPH

Pfizer

Disclosure(s): Pfizer Inc.: Stocks/Bonds (Public Company)

Poster(s):

• (P-40) Impact of case and control selection on influenza vaccine effectiveness (VE) among adults aged 40 years and older hospitalized with acute respiratory illness (ARI) during 2022-2023 using a test negative design (TND): secondary analysis of the North America multi-specimen study
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-53) Trends in Co-administration of Adult Vaccinations in the US Retail Pharmacy Setting
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT